Metabolic Profiling in Multiple Sclerosis and Other Disorders by Quantitative Analysis of Cerebrospinal Fluid Using Nuclear Magnetic Resonance Spectroscopy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|7|1016-1025

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.7, 2011-07, pp. : 1016-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders

By  

Current Medicinal Chemistry, Vol. 15, Iss. 1, 2008-01 ,pp. : 15-36

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacometabonomics Technique to Identify Warfarin Response Using Nuclear Magnetic Resonance Spectroscopy

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 9, 2017-12 ,pp. : 740-747

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomic-Based Biomarker Discovery with Emphasis on Cerebrospinal Fluid and Multiple Sclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 3, 2006-06 ,pp. : 147-158

Bentham Science Publishers

Access to resources Recommend Favorite

Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance

By Hess S.   Teubert U.   Ortwein J.   Eger K.  

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 4, 2001-12 ,pp. : 301-311

Elsevier

Access to resources Recommend Favorite

Fluorine Nuclear Magnetic Resonance, a Privileged Tool for Metabolic Studies of Fluoropyrimidine Drugs

By  

Current Drug Metabolism, Vol. 1, Iss. 3, 2000-11 ,pp. : 271-303

Bentham Science Publishers

Access to resources Recommend Favorite